Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.4887
Delayed Data
As of May 26
 -0.0102 / -2.04%
Today’s Change
0.47
Today|||52-Week Range
2.00
-60.27%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.50
Today’s open0.49
Day’s range0.48 - 0.50
Volume229,323
Average volume (3 months)166,377
Market cap$18.9M
Dividend yield--
Data as of 4:00pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book0.41

Competitors

 Today’s
change
Today’s
% change
PRANPrana Biotechnology ...-0.02-0.94%
ARGSArgos Therapeutics I...+0.05+13.39%
ONTXOnconova Therapeutic...-0.02-1.01%
CAPRCapricor Therapeutic...-0.01-1.20%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateSeptember 14, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts